The Team
  Highlights
  Inlicensing to outlicensing
  Our Philosophy
  Social Commitments
 
FROM INLICENSING INTO INDIA TO OUTLICENSING TO THE WORLD.
 
Past 
Created Markets in India
Oncology - Cyclophosphamide, Cisplatin, Bleomycin - Nippon Kayaku
    (Japan) / Asta Medica (Germany).
 
Pain and Spasm – Camylofin and Methocarbamol - Asta Medica / A.H.
    Robins (USA).
 
Anaesthetic – Glycopyrrolate – A.H. Robins
 
Respiratory Stimulants – Doxapram – A.H. Robins.
 
Iron Supplements – Iron Polymaltose – Hausmann Laboratories
    (Switzerland).
 
Anti-tussive – Prenoxdiazine – Chinoin (Hungary)

Present

Introduced Patented Products based on NDDS
(Marketed in India and out-Licensed for the Developing Countries)

  

Future

Patents driven by NDDS, Nano and Dendrimers
(To be marketed in India and to be out Licensed to the developed countries)

 
Present 
Introduced Patented Products based on NDDS
(Marketed in India and out-Licensed for the Developing Countries)
 
Camylofin combinations with Nimesulide/ Diclofenac – ANAFORTAN
    GROUP (Licensed to NPIL)
 
Methocarbamol combinations with Diclofenac / Nimesulide.- ROBI GROUP  
    (Licensed to NPIL)
 
Cefixime once a day - CEFI OD.(Licensed to NPIL)
 
Cefixime + Cloxacillin + Lactobacillus - CEFI XL. (Licensed to NPIL)
Future
Patents driven by NDDS, Nano and Dendrimers
(To be marketed in India and to be out Licensed to the developed countries)
 
Silver Nano Gel for burns, wounds, acne etc.
 
Gold Nano Gel for cosmetics.
 
Dendrimers for cosmetics, antimicrobials etc.
 
Parenterals to Oral Delivery
 
Colon / Brain and Site Specific Targeting

   
© 2001 - 2007 Khandelwal Laboratories Pvt.Ltd. All rights reserved.